Bacillus subtilis 1579 Fermentation for Polyphenol-to-PCA Conversion
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The poor bioavailability and low tissue distribution of dietary polyphenols constrain their efficacy in preventing degenerative diseases, as they are not effectively converted into more bioavailable metabolites like protocatechuic acid (PCA) in the body, limiting their health benefits.
Innovation Solution
Utilizing Bacillus subtilis 1579 or its active variants to convert polyphenols, such as quercetin, into protocatechuic acid (PCA) through microbial fermentation, enhancing the production of PCA in both human and agricultural animals, thereby increasing the bioavailability and health benefits.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If dietary polyphenols are consumed, then health benefits are claimed, but bioavailability is poor and tissue distribution is low
Solution Approach 1:
The patent introduces specific bacterial strains (Bacillus subtilis 1579 and other probiotics) as intermediary agents that convert dietary polyphenols into more bioavailable metabolites. These bacteria act as mediators between the polyphenols consumed and the body's absorption systems, transforming the parent compounds into metabolites with enhanced bioavailability and tissue distribution properties.
Solution Approach 2:
The patent changes the chemical parameters of polyphenols through microbial fermentation, transforming them into different metabolitic forms (such as protocatechuic acid, hydroxycinnamic acids, and other phenolic compounds). This parameter change in molecular structure and chemical properties enables improved absorption and tissue distribution while maintaining health benefits.
2Reliability
If polyphenols are consumed, then anti-inflammatory and antioxidant effects are observed, but conversion to bioavailable metabolites is insufficient
Solution Approach 1:
Specific bacterial strains serve as intermediary converters that facilitate the transformation of polyphenols into bioavailable metabolites. These microbial intermediaries possess enzymatic capabilities (such as hydrolysis, decarboxylation, and oxidation enzymes) that efficiently convert parent polyphenol compounds into active metabolites with enhanced efficacy.
Solution Approach 2:
The patent utilizes probiotic bacteria that can be administered to replicate the beneficial metabolic conversion process within the host organism. The bacteria copy the function of polyphenol metabolism that would otherwise require complex enzymatic pathways, providing a simplified and effective conversion mechanism that enhances metabolite production.
3Reliability
If exogenous protocatechuic acid is supplemented, then health benefits are provided, but cost increases and efficacy is lost to breakdown during storage and gastrointestinal tract
Solution Approach 1:
The patent employs probiotic bacteria that perform preliminary conversion of polyphenols into stable, bioavailable metabolites before these metabolites reach the gastrointestinal tract. This preliminary action occurs in the upper gastrointestinal tract where the bacteria reside, protecting the metabolites from subsequent breakdown by creating them in a more stable form that resists degradation during transit through the gastrointestinal system.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The conversion process decreases inflammation, cortisol levels, and improves milk quality and production in agricultural animals, while providing anti-inflammatory and antioxidant effects in humans.
Implementation Method 1
Utilizing Bacillus subtilis 1579 or its active variants to convert polyphenols, such as quercetin, into protocatechuic acid (PCA) through microbial fermentation
Data Source
AI summary
Compositions and methods for converting at least one polyphenol to protocatechuic acid (PCA) using Bacillus subtilis 1579, or active variants thereof, are provided. Conversion of polyphenols, such as quercetin, to PCA can decrease inflammation, decrease cortisol levels, and increase milk quality and milk production quantity in milk-producing agricultural animals. Accordingly, provided herein are compositions comprising B. subtilis 1579, or an active variant thereof, for administration to humans for decreasing inflammation or for administration to milk-producing agricultural animals for decreasing inflammation, decreasing cortisol levels, and increasing milk quality and milk production.